[HTML][HTML] Improved HDAC inhibition, stronger cytotoxic effect and higher selectivity against leukemias and lymphomas of novel, tricyclic vorinostat analogues

B Bieszczad, D Garbicz, M Świtalska, MK Dudek… - Pharmaceuticals, 2021 - mdpi.com
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …

Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues.

B Bieszczad, D Garbicz, M Świtalska… - Pharmaceuticals …, 2021 - search.ebscohost.com
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …

Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues

B Bieszczad, D Garbicz, M Świtalska, MK Dudek… - …, 2021 - eprints.ibb.waw.pl
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …

Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues

B Bieszczad, D Garbicz, M Świtalska… - …, 2021 - search.proquest.com
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …

[PDF][PDF] Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues

B Bieszczad, D Garbicz, M Switalska, MK Dudek… - …, 2021 - academia.edu
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …

Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues

B Bieszczad, D Garbicz, M Świtalska… - Pharmaceuticals …, 2021 - pubmed.ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …

Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues.

B Bieszczad, D Garbicz, M Świtalska… - Pharmaceuticals …, 2021 - europepmc.org
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …

[PDF][PDF] Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues

B Bieszczad, D Garbicz, M Switalska, MK Dudek… - …, 2021 - researchgate.net
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …

[HTML][HTML] Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues

B Bieszczad, D Garbicz, M Świtalska, MK Dudek… - …, 2021 - ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment.
Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in …